Cost-effectiveness analysis of tislelizumab combined with chemotherapy as first-line treatent for advanced or metastatic esophageal squamous cell carcinomas
ZHAO Yingying, JU Wenxiang, ZHANG Xiaohan, LU Luolan, SHEN Aizong
Chinese Journal of Hospital Pharmacy . 2025, (4): 418 -426 .  DOI: 10.13286/j.1001-5213.2025.04.08

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat